Background Image
Table of Contents Table of Contents
Previous Page  52 / 52
Information
Show Menu
Previous Page 52 / 52
Page Background

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

Pearinda 4.

Each tablet contains 4 mg perindopril

tert

-butylamine. Reg. No.: RSA S3 A41/7.1.3/0649. NAM NS2 10/7.1.3/0476.

Pearinda 8.

Each tablet contains 8 mg perindopril

tert

-butylamine. Reg. No.: RSA S3

A41/7.1.3/0650. NAM NS2 10/7.1.3/0477. For full prescribing information, refer to the package insert approved by the Medicines Control Council, April 2009.

Pearinda Plus 4.

Each tablet contains 4 mg perindopril

tert

-

butylamine and 1,25 mg indapamide. Reg. No.: RSA S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing information, refer to the package insert approved by the Medicines Control Council, April 2010.

1)

The

EUROPA study Investigators. “Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA

study)”. The Lancet 2003;362:782-788.

2)

The PREAMI study Investigators. “Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodelling and clinical outcome. Results of the randomized

perindopril and remodelling in elderly with acute myocardial infarction (PREAMI) study”. Arch Intern Med 2006;166:659-666.

3)

PROGRESS Collaborative Group. “Randomised trial of a perindopril-based blood-pressure-

lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack”. The Lancet 2001;358:1033-41.

4)

Guerin AP,

et al.

“Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage

Renal Failure”. Circulation 2001;103;987-992.

5)

Department of Health website

http/

/www.doh.gov.za

– Accessed on 29/03/2016.

PAF291/04/2016.

Perindopril has proven outcomes in:

đŏ +.+* .5ŏ .0!.5ŏ %/! /!

1

đŏ 10!ŏ 5+ . % (ŏ *" . 0%+*

2

đŏ 0.+'!

3

đŏ * ġ/0 #!ŏ !* (ŏ %(1.!

4

Need

endurance

3$!*ŏ0.! 0%*#ŏ

ŏ %/! /!ĕ

0$!ŏ ""+. (!

5

endurance

ġ%*$% %0+.

A Lupin Group Company